Jaykay Enterprises Ltd
JAYKAYJaykay Enterprises Ltd's earnings have outrun its stock. EPS grew +3,031.6% in a year against a +23.4% price move.
The sharpest disagreement: profits are rising, but only 3% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (9 weeks in) while the P/E sits at the 59th percentile of its own 10-year range. Underneath, the last four quarters read improving, and 3% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Jaykay Enterprises Ltd trades at ₹167, in a confirmed uptrend and 9 weeks into that stage. That is −0.7% against its own 200-day average. It sits at 39% of a 52-week range of ₹127 to ₹231. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a confirmed uptrend — week 9 of stage 2, confirmed. At ₹167 it trades −0.7% versus its 200-day average and sits at 39% of its 52-week range (₹127–₹231).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +7,614% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Jaykay Enterprises Ltd trades at 32.6× P/E, mid-range by its own standards (59th percentile). Its long-run median P/E is 28.8×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 32.6× is mid-range by its own standards (59th percentile), against a long-run median of 28.8× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +3,031.6% against a +23.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +41.0%/yr price move, ~+40.7%/yr came from earnings growth and ~+0.3 pp from the multiple (roughly flat). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Jaykay Enterprises Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +218.5% | +76.4% | — | — |
| Profit | +2,985.7% | +200.0% | +52.7% | +40.9% |
| EPS | +3,031.6% | +198.7% | +43.0% | +33.5% |
| Share price | +23.4% | +59.5% | +41.0% | +50.7% |
4-Factor Sector Score
49.0/100 — rank 13 of 24 in Aerospace & Defence - Equipments · 62% evidence confidence
Jaykay Enterprises Ltd scores 49.0 out of 100 against the 24 companies it is compared with in Aerospace & Defence - Equipments, ranking 13. Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 20.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
The four contributions add to the total exactly: 25.8 + 6.8 + 11.5 + 4.9 = 49. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Jaykay Enterprises Ltd reported ₹61.0 Cr of revenue in the Mar 26 quarter, +454.5% year on year. That is the 4th straight quarter of year-on-year growth. The last full year, FY26, came in at ₹258 Cr. The last four reported quarters add to ₹239 Cr.
FY26 revenue came in at ₹258 Cr (+218.5% on the year). The latest quarter (Mar 26) printed ₹61.0 Cr, +454.5% year on year — the 4th consecutive quarter of year-over-year growth.
Acceleration check: trailing-twelve-month revenue grew +195.1% over the last 4 quarters against +112.4%/yr over the last 8 — accelerating; TTM profit +2,985.7% vs +364.8%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Jaykay Enterprises Ltd's operating margin is −10.0% in the Mar 26 quarter, +34.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged −1,774.0% to 16.0%. The current quarter sits inside that band.
The latest quarter's operating margin is −10.0%, +34.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −1,774.0%–16.0%, and FY26's 16.0% is the top of that band — a record year.
Why the margin moved: operating margin went +33.6 pp year on year while gross margin went +5.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Jaykay Enterprises Ltd earned ₹180 Cr of net profit in the Mar 26 quarter. That quarter carries a one-off item larger than its own revenue, so the year-on-year figure is an artefact rather than a trading result. Full-year FY26 profit was ₹216 Cr. The 10-year compound rate is 40.9%. That is 295.1% of the quarter's revenue.
Mar 26 profit was ₹180 Cr, null year on year. On the full year, FY26 printed ₹216 Cr (+2,985.7%), and the 10-year compound rate is 40.9%.
🚨 Read this profit with care: at ₹180 Cr it is larger than the whole quarter's revenue of ₹61.0 Cr — no operating business earns more than it sells, so this is a one-off item (a debt-to-equity conversion, a tax write-back or an asset sale), not money the business earned. The underlying operations are running at −10.0% operating margin; the year-on-year jump and any P/E built on this number are artefacts of the one-off, not a real earnings turn.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 3% of Jaykay Enterprises Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹40.0 Cr of operating cash against ₹216 Cr of profit. After ₹36.0 Cr of capital spending, ₹4.0 Cr was left as free cash.
FY26: operating cash of ₹40.0 Cr against reported profit of ₹216 Cr, leaving free cash of ₹4.0 Cr after ₹36.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 3% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 3%: the cash cycle stretched 355 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 355 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Jaykay Enterprises Ltd's cash conversion cycle runs 355 days in FY26, up from 0 days in FY21. Capital spending ran ₹145 Cr over the last 3 years. At FY26 sales of ₹258 Cr each day of that cycle holds about ₹0.7 Cr, so roughly ₹251 Cr sits inside the business at any moment.
FY26: debtors at 134 days, inventory at 901 days — roughly 29.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 355 days, looser than FY21's 0.
The full loop: cash goes out to suppliers and production on day 0; stock waits 901 days to sell; customers pay about 134 days after that; and suppliers themselves are paid at 681 days — netting out to the 355-day cycle.
In money terms: at FY26 sales of ₹258 Cr, each day of the cycle holds about ₹0.7 Cr — so the 355-day loop keeps roughly ₹251 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹145 Cr over the last 3 fiscal years against ₹23.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹55.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Jaykay Enterprises Ltd earns a ROCE of 8% in FY26. That is up from a trough of −1% in FY20. Return on invested capital clears the cost of that capital by −3.4 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 83.7% net margin on 0.31× asset turns.
FY26 ROCE is 8%, recovered from a FY20 trough of −1% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 83.7% net margin × 0.31× asset turns × 1.21× balance-sheet leverage ≈ 31.4% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 8.6% − 12.0% = a −3.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Jaykay Enterprises Ltd carries total debt of ₹39.0 Cr against shareholder equity of ₹697 Cr as of Mar 26, a debt-to-equity of 0.06 — effectively unlevered. On the annual view that ratio went from 0.06 in FY22 to 0.06 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹39.0 Cr against shareholder equity of ₹697 Cr — a debt-to-equity of 0.06. On the annual view, debt-to-equity went from 0.06 (FY22) to 0.06 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 8.9 points of Jaykay Enterprises Ltd over 8 quarters, the biggest move on the register. That takes promoters to 65.2% of the company. Domestic institutions moved −2.3 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +8.9 points over 8 quarters to 65.2%; Domestic institutions: −2.3 points over 8 quarters to 0.0%; Foreign institutions: +0.0 points over 8 quarters to 0.2%.
Why the register moved: promoters drove it (+8.9 points), absorbed on the other side by domestic institutions (−2.3 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Jaykay Enterprises Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sigma Advanced System LtdSIGMAADV | 72.6/100Favorable setup93% evidence | LEADER | 24.0/35 Revenue 100% · PAT 100% · OPM change -12 pp 83% evidence | 16.6/25 ROCE 60.8% · OPM 17% 95% evidence | 12.0/20 P/E 42.6× · PEG 2.35 100% evidence | 20.0/20 RS sector 105.2% · RS bench 142.5% · 1Y 494.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 16.6 + 12 + 20 = 72.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Sika Interplant Systems LtdSIKA | 72.6/100Favorable setup90% evidence | TURNING | 28.4/35 Revenue 43% · PAT 38.1% · OPM change 7.9 pp 88% evidence | 21.9/25 ROCE 34.6% · OPM 25.2% 100% evidence | 12.9/20 P/E 67.4× · PEG 1.01 100% evidence | 9.4/20 RS sector -10.2% · RS bench 6% · 1Y -1.7%3 of 7 weeks ahead 70% evidence |
| Exact sum: 28.4 + 21.9 + 12.9 + 9.4 = 72.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Astra Microwave Products LtdASTRAMICRO | 70.5/100Favorable setup96% evidence | LEADER | 21.0/35 Revenue 10.6% · PAT 27% · OPM change 4 pp 88% evidence | 19.4/25 ROCE 20.2% · OPM 33% 100% evidence | 10.8/20 P/E 91.6× · PEG 1.19 100% evidence | 19.3/20 RS sector 30.4% · RS bench 61.4% · 1Y 90.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 19.4 + 10.8 + 19.3 = 70.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Paras Defence and Space Technologies LtdPARAS | 66.4/100Favorable setup78% evidence | LEADER | 21.8/35 Revenue 30.4% · PAT 43.5% · OPM change -1 pp 83% evidence | 16.8/25 ROCE 16.9% · OPM 25% 76% evidence | 9.2/20 P/E 118× · PEG — 50% evidence | 18.6/20 RS sector 27.1% · RS bench 57.1% · 1Y 60.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 16.8 + 9.2 + 18.6 = 66.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5MTAR Technologies LtdMTARTECH | 63.2/100Mixed-positive evidence90% evidence | FADING | 30.7/35 Revenue 53.5% · PAT 100% · OPM change 6 pp 100% evidence | 13.9/25 ROCE 15.1% · OPM 24% 100% evidence | 6.3/20 P/E 129× · PEG — 50% evidence | 12.3/20 RS sector 21.9% · RS bench 44.7% · 1Y 280.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 30.7 + 13.9 + 6.3 + 12.3 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Apollo Micro Systems LtdAPOLLO | 59.9/100Mixed-positive evidence96% evidence | LEADER | 21.9/35 Revenue 60.9% · PAT 92.9% · OPM change 1 pp 88% evidence | 14.2/25 ROCE 14.5% · OPM 23% 100% evidence | 7.1/20 P/E 128× · PEG 1.6 100% evidence | 16.7/20 RS sector 6.5% · RS bench 32% · 1Y 126.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 14.2 + 7.1 + 16.7 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Vinyas Innovative Technologies LtdVINYAS | 59.3/100Thin evidence · provisional57% evidence | TURNING | 21.7/35 Revenue 65% · PAT 100% · OPM change 3 pp 48% evidence | 18.5/25 ROCE 21.4% · OPM 13% 95% evidence | 10.9/20 P/E 51.1× · PEG — 15% evidence | 8.2/20 RS sector -17.5% · RS bench 6% · 1Y -6.9%10 of 11 weeks ahead 70% evidence |
| Exact sum: 21.7 + 18.5 + 10.9 + 8.2 = 59.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Data Patterns (India) LtdDATAPATTNS | 58.1/100Mixed-positive evidence100% evidence | FADING | 21.5/35 Revenue 33.9% · PAT 24.2% · OPM change -5 pp 100% evidence | 18.6/25 ROCE 21.9% · OPM 27% 100% evidence | 5.0/20 P/E 88.7× · PEG 3.94 100% evidence | 13.0/20 RS sector 5% · RS bench 30.1% · 1Y 59.9%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 18.6 + 5 + 13 = 58.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 9Azad Engineering LtdAZAD | 57.4/100Mixed-positive evidence89% evidence | FADING | 24.5/35 Revenue 32.2% · PAT 54% · OPM change 2 pp 88% evidence | 12.9/25 ROCE 11.9% · OPM 38% 100% evidence | 8.0/20 P/E 111× · PEG 2.29 65% evidence | 12.0/20 RS sector 1.6% · RS bench 27% · 1Y 47.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 12.9 + 8 + 12 = 57.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Ideaforge Technology LtdIDEAFORGE | 57.1/100Mixed-positive evidence68% evidence | LEADER | 24.6/35 Revenue 41% · PAT 71.4% · OPM change 152 pp 65% evidence | 4.6/25 ROCE -2.8% · OPM 44% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 17.9/20 RS sector 25.6% · RS bench 53.6% · 1Y 85.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 4.6 + 10 + 17.9 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Hindustan Aeronautics LtdHAL | 56.2/100Mixed-positive evidence96% evidence | BREAKING OUT | 11.0/35 Revenue 6.8% · PAT 9% · OPM change -3 pp 88% evidence | 21.1/25 ROCE 32% · OPM 36% 100% evidence | 15.2/20 P/E 34.1× · PEG 1.18 100% evidence | 8.9/20 RS sector -18.6% · RS bench 4% · 1Y 2.1%8 of 12 weeks ahead 100% evidence |
| Exact sum: 11 + 21.1 + 15.2 + 8.9 = 56.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Rossell Techsys LtdROSSTECH | 54.1/100Mixed-positive evidence83% evidence | FADING | 29.0/35 Revenue 82.9% · PAT 68.8% · OPM change 1.8 pp 100% evidence | 7.4/25 ROCE 11.5% · OPM 14.4% 100% evidence | 9.0/20 P/E 136× · PEG — 15% evidence | 8.7/20 RS sector -3.2% · RS bench 20.7% · 1Y 64.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 29 + 7.4 + 9 + 8.7 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Jaykay Enterprises Ltdthis pageJAYKAY | 49.0/100Mixed-negative evidence62% evidence | ASLEEP | 25.8/35 Revenue 100% · PAT 100% · OPM change 34 pp 62% evidence | 6.8/25 ROCE 8.2% · OPM -10% 95% evidence | 11.5/20 P/E 32.6× · PEG — 15% evidence | 4.9/20 RS sector -20.9% · RS bench -6.2% · 1Y 20.6%6 of 10 weeks ahead 70% evidence |
| Exact sum: 25.8 + 6.8 + 11.5 + 4.9 = 49 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 20.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 14Mishra Dhatu Nigam LtdMIDHANI | 45.7/100Mixed-negative evidence96% evidence | FADING | 16.3/35 Revenue 12.6% · PAT 18.9% · OPM change -2 pp 88% evidence | 13.7/25 ROCE 11.3% · OPM 21% 100% evidence | 7.4/20 P/E 56.4× · PEG 5.62 100% evidence | 8.3/20 RS sector -16.9% · RS bench 5.1% · 1Y -2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.7 + 7.4 + 8.3 = 45.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Dynamatic Technologies LtdDYNAMATECH | 43.8/100Mixed-negative evidence89% evidence | FADING | 16.2/35 Revenue 15.5% · PAT -23.3% · OPM change 1 pp 88% evidence | 10.2/25 ROCE 10% · OPM 11% 100% evidence | 10.3/20 P/E 140× · PEG 1.42 65% evidence | 7.1/20 RS sector -12.3% · RS bench 10.4% · 1Y 47.5%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 10.2 + 10.3 + 7.1 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Zen Technologies LtdZENTEC | 41.9/100Mixed-negative evidence69% evidence | ASLEEP | 5.0/35 Revenue -23.4% · PAT -27.8% · OPM change -14 pp 95% evidence | 16.6/25 ROCE 16.2% · OPM 27% 76% evidence | 10.5/20 P/E 80.7× · PEG — 15% evidence | 9.8/20 RS sector -6.5% · RS bench 6.5% · 1Y -8.7%8 of 10 weeks ahead 70% evidence |
| Exact sum: 5 + 16.6 + 10.5 + 9.8 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Bharat Electronics LtdBEL | 41.7/100Mixed-negative evidence100% evidence | ASLEEP | 14.0/35 Revenue 19.8% · PAT 11.8% · OPM change -3 pp 100% evidence | 18.6/25 ROCE 36.5% · OPM 25% 100% evidence | 7.3/20 P/E 46.1× · PEG 3.54 100% evidence | 1.8/20 RS sector -28% · RS bench -8% · 1Y -1.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14 + 18.6 + 7.3 + 1.8 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Aequs LtdAEQUS | 36.4/100Thin evidence · provisional51% evidence | BREAKING OUT | 15.1/35 Revenue 44.3% · PAT — · OPM change -7.3 pp 74% evidence | 1.3/25 ROCE 1.6% · OPM 3.7% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 15.1 + 1.3 + 10 + 10 = 36.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Avantel LtdAVANTEL | 35.7/100Mixed-negative evidence77% evidence | TURNING | 10.1/35 Revenue -3.2% · PAT -67.2% · OPM change 4.6 pp 100% evidence | 9.2/25 ROCE 9.6% · OPM 24.8% 100% evidence | 8.7/20 P/E 251× · PEG — 15% evidence | 7.7/20 RS sector -11.9% · RS bench 0.1% · 1Y 19%8 of 11 weeks ahead 70% evidence |
| Exact sum: 10.1 + 9.2 + 8.7 + 7.7 = 35.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20AXISCADES Technologies LtdAXISCADES | 35.4/100Mixed-negative evidence96% evidence | ASLEEP | 15.4/35 Revenue 12.4% · PAT -4.3% · OPM change -1.7 pp 88% evidence | 12.3/25 ROCE 15.3% · OPM 12.3% 100% evidence | 4.9/20 P/E 83.6× · PEG 3.04 100% evidence | 2.8/20 RS sector -21.3% · RS bench -1.3% · 1Y 13.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 12.3 + 4.9 + 2.8 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21NIBE LtdNIBE | 32.4/100Adverse evidence65% evidence | TURNING | 9.6/35 Revenue -6.7% · PAT -80% · OPM change 3 pp 83% evidence | 7.6/25 ROCE 4.8% · OPM 20% 76% evidence | 8.5/20 P/E 380× · PEG — 15% evidence | 6.7/20 RS sector -29.8% · RS bench 11.1% · 1Y -17%11 of 11 weeks ahead 70% evidence |
| Exact sum: 9.6 + 7.6 + 8.5 + 6.7 = 32.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Bharat Dynamics LtdBDL | 29.4/100Adverse evidence83% evidence | ASLEEP | 7.6/35 Revenue -27% · PAT -23.6% · OPM change -5 pp 88% evidence | 12.9/25 ROCE 13.8% · OPM 12% 100% evidence | 5.0/20 P/E 109× · PEG 4.44 65% evidence | 3.9/20 RS sector -22.4% · RS bench -11.8% · 1Y -24.4%2 of 10 weeks ahead 70% evidence |
| Exact sum: 7.6 + 12.9 + 5 + 3.9 = 29.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23BEML LtdBEML | 26.3/100Adverse evidence90% evidence | ASLEEP | 6.5/35 Revenue 8.1% · PAT -51.5% · OPM change -11 pp 88% evidence | 5.3/25 ROCE 7.7% · OPM 15% 100% evidence | 9.5/20 P/E 103× · PEG 1.18 100% evidence | 5.0/20 RS sector -19.9% · RS bench -6.2% · 1Y -15.6%5 of 10 weeks ahead 70% evidence |
| Exact sum: 6.5 + 5.3 + 9.5 + 5 = 26.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24DCX Systems LtdDCXINDIA | 25.1/100Adverse evidence67% evidence | ASLEEP | 8.2/35 Revenue -31.4% · PAT -80% · OPM change -2 pp 83% evidence | 3.4/25 ROCE 0.9% · OPM -0.2% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -27% · RS bench -12.4% · 1Y -32%5 of 10 weeks ahead 70% evidence |
| Exact sum: 8.2 + 3.4 + 10 + 3.5 = 25.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Jaykay Enterprises Ltd's share price today?
Jaykay Enterprises Ltd trades at ₹167, +23.4% over the past year. The company is valued at ₹2,180 Cr. The stock sits at 39% of its 52-week range of ₹127–₹231, −0.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 9 weeks in. — as of 31 July 2026.
What were Jaykay Enterprises Ltd's latest quarterly results?
Jaykay Enterprises Ltd reported revenue of ₹61.0 Cr and net profit of ₹180 Cr for the Mar 26 quarter. Earnings per share were ₹15.12. The operating margin was −10.0%, 34.0 pp higher than a year earlier. — as of 31 July 2026.
What is Jaykay Enterprises Ltd's revenue?
Jaykay Enterprises Ltd reported revenue of ₹61.0 Cr in the Mar 26 quarter, +454.5% year on year. For the full FY26 fiscal year, revenue was ₹258 Cr (+218.5%). — as of 31 July 2026.
What is Jaykay Enterprises Ltd's profit?
Jaykay Enterprises Ltd earned ₹180 Cr of net profit in the Mar 26 quarter. Full-year FY26 profit was ₹216 Cr. The operating margin ran −10.0% in the latest quarter. — as of 31 July 2026.
What is Jaykay Enterprises Ltd's market cap?
Jaykay Enterprises Ltd's market capitalisation is ₹2,180 Cr at a share price of ₹167. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Jaykay Enterprises Ltd's P/E ratio?
Jaykay Enterprises Ltd trades at a P/E of 32.6×, at the 59th percentile of its own 10-year range, against a long-run median of 28.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Jaykay Enterprises Ltd pay a dividend?
No — Jaykay Enterprises Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Jaykay Enterprises Ltd overvalued?
On its own history, Jaykay Enterprises Ltd looks mid-range against its own history: its P/E of 32.6× sits at the 59th percentile of its 10-year range (long-run median 28.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 31 July 2026.
How is Jaykay Enterprises Ltd performing?
Jaykay Enterprises Ltd is in a confirmed uptrend, 9 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Jaykay Enterprises Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 9 of stage 2), trading −0.7% versus its 200-day average and at 39% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Jaykay Enterprises Ltd beating the market?
Not lately — on a trailing-13-week view Jaykay Enterprises Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +7,614% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Jaykay Enterprises Ltd's share price go up?
This page publishes no price forecast for Jaykay Enterprises Ltd. What it measures instead: the share price is ₹167, the price is in a confirmed uptrend 9 weeks in. Its P/E of 32.6× sits at the 59th percentile of its own 10-year range. — as of 31 July 2026.
Who owns Jaykay Enterprises Ltd?
Promoters hold 65.2% of Jaykay Enterprises Ltd, foreign institutions 0.2%, domestic institutions 0.0% and the public 34.6% (latest quarter). The biggest move on the register over the last two years: Promoters added 8.9 points over 8 quarters. — as of 31 July 2026.
Does Jaykay Enterprises Ltd have too much debt?
No — Jaykay Enterprises Ltd's debt-to-equity is 0.06, and operating profit covers the interest bill 6×. FY26 borrowings were ₹39.0 Cr against equity of ₹690 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Jaykay Enterprises Ltd's capex?
Jaykay Enterprises Ltd spent ₹145 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹36.0 Cr, with ₹55.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Jaykay Enterprises Ltd's cash flow?
Jaykay Enterprises Ltd generated ₹40.0 Cr of operating cash flow in FY26 and ₹4.0 Cr of free cash flow after ₹36.0 Cr of capital spending. Reported profit that year was ₹216 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Jaykay Enterprises Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 3% of Jaykay Enterprises Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹40.0 Cr against reported profit of ₹216 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
Where is Jaykay Enterprises Ltd in its business cycle?
Jaykay Enterprises Ltd's FY26 operating margin was 16.0%, against a 13-year band of −1,774.0%–16.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran −10.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Jaykay Enterprises Ltd story?
The sharpest disagreement: profits are rising, but only 3% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Jaykay Enterprises Ltd a stock worth studying right now?
This is not investment advice. The machine read: Jaykay Enterprises Ltd's earnings have outrun its stock. EPS grew +3,031.6% in a year against a +23.4% price move. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.